Case Studies 2

A major pharmaceutical company faced a set of strategic questions concerning the future of its hemato-oncology franchise: should it invest, and if so, how much and into which segments or technologies? How will the competitive environment evolve, and what key assets are needed to win? What are the client’s gaps and how can they be filled? Easton Associates provided a comprehensive analysis of the future hemato-oncology marketplace and detailed strategic options to optimize the current and future value of the franchise. The outcome was a clear set of recommendations, including specific products, market segments, geographies and areas of the value chain for focus, as well as recommendations for products to divest or partner.